PFE — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Pfizer Inc.
Healthcare · $28.32
1.0
/10
Avoid
How this score works →
Regime
Bullish
vs SMA200
SMA200 Distance
+11.2%
Above trend
Volatility
Normal
Average premiums
Momentum
Positive
Price direction
About Pfizer Inc.
Pfizer sells prescription drugs and vaccines — Eliquis, Paxlovid, and oncology treatments drive most revenue. Very low beta (~0.4), deep dividend yield near 6%, but payout ratio stretched above 100%. High option premiums for a pharma name; attractive for put sellers seeking income, though pipeline risk and debt load deserve attention.
Drug Manufacturers — General
Market Cap
$161.1B
P/E Ratio
20.8
Dividend
607.00%
Beta
0.39
52-Week Range Current: $28.32
$20.92 $28.75
Earnings
2026-05-05
30 days away
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE